Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

Abstract Introduction Cancer Immunotherapy has recently emerged as a promising and effective modality to treat different malignancies. Antigenic profiling of cancer tissues and determination of any pre-existing immune responses to cancer antigens may help predict responses to immune intervention in...

Full description

Bibliographic Details
Published in:Journal of Translational Medicine
Main Authors: Afsheen Raza, Maysaloun Merhi, Varghese Philipose Inchakalody, Roopesh Krishnankutty, Allan Relecom, Shahab Uddin, Said Dermime
Format: Article
Language:English
Published: BMC 2020-03-01
Subjects:
Cancer immunotherapy
Cancer testis antigen
Cancer vaccine
Immune checkpoint inhibitors
NY-ESO-1
Tumor microenvironment
Online Access:http://link.springer.com/article/10.1186/s12967-020-02306-y

Internet

http://link.springer.com/article/10.1186/s12967-020-02306-y

Similar Items